• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与甲状腺眼病眶脂肪扩张的关联。

Association of obesity with orbital fat expansion in thyroid eye disease.

作者信息

Kuo Po-Chin, Kuo Shu-Chun, Teng Yi-Shan, Lai Chun-Chieh

机构信息

Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No. 138, Sheng Li Road, Tainan, 704, Taiwan.

Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan.

出版信息

BMC Ophthalmol. 2025 Jan 2;25(1):2. doi: 10.1186/s12886-024-03824-9.

DOI:10.1186/s12886-024-03824-9
PMID:39748316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694364/
Abstract

BACKGROUND

To investigate the association between obesity and orbital fat expansion in proptosis of thyroid eye disease.

METHODS

This observational study retrospectively enrolled 87 participants who received orbital fat decompression surgery for thyroid eye disease. Primary outcome measures included average body mass index (BMI) and the proportion of the study sample with overweight and obesity, compared with the general Taiwanese population. Secondary outcome measures included the association of obesity with proptosis severity, removed fat volume, and thyroid status.

RESULTS

The average BMI (25.59 ± 4.36 kg/m) of the study sample was significantly higher than that in the general population of Taiwan (24.5 kg/m; P = 0.012). Participants with overweight (19.52 ± 3.52 mm) and obesity (21.25 ± 3.76 mm) exhibited significantly more severe proptosis than participants without overweight (18.05 ± 3.37 mm) and without obesity (18.09 ± 3.02 mm; P = 0.029 and P < 0.001, respectively). In addition, a significantly greater orbital fat volume was removed from the group with obesity (4.61 ± 1.17 ml) versus that without obesity (3.57 ± 1.12 ml; P = 0.021). A positive correlation between BMI and removed fat volume was noted (correlation coefficient = 0.291, P = 0.005). BMI was an independent factor predicting both proptosis severity (P < 0.001) and removed orbital fat volume (P = 0.02).

CONCLUSIONS

Obesity is associated with orbital fat expansion and consequently more severe proptosis in thyroid eye disease. Weight control may be a potential strategy to prevent thyroid-associated exophthalmos.

摘要

背景

探讨肥胖与甲状腺眼病眼球突出时眶脂肪扩张之间的关联。

方法

这项观察性研究回顾性纳入了87例因甲状腺眼病接受眶脂肪减压手术的参与者。主要观察指标包括平均体重指数(BMI)以及与台湾普通人群相比,研究样本中超重和肥胖者的比例。次要观察指标包括肥胖与眼球突出严重程度、去除的脂肪量以及甲状腺状态之间的关联。

结果

研究样本的平均BMI(25.59±4.36kg/m²)显著高于台湾普通人群(24.5kg/m²;P = 0.012)。超重(19.52±3.52mm)和肥胖(21.25±3.76mm)的参与者比非超重(18.05±3.37mm)和非肥胖(18.09±3.02mm)的参与者表现出明显更严重的眼球突出(分别为P = 0.029和P < 0.001)。此外,肥胖组(4.61±1.17ml)去除的眶脂肪量明显多于非肥胖组(3.57±1.12ml;P = 0.021)。BMI与去除的脂肪量之间存在正相关(相关系数 = 0.291,P = 0.005)。BMI是预测眼球突出严重程度(P < 0.001)和去除的眶脂肪量(P = 0.02)的独立因素。

结论

肥胖与眶脂肪扩张相关,因此在甲状腺眼病中会导致更严重的眼球突出。控制体重可能是预防甲状腺相关性突眼的一种潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4635/11694364/965d3734b8b0/12886_2024_3824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4635/11694364/22469bd94c2e/12886_2024_3824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4635/11694364/965d3734b8b0/12886_2024_3824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4635/11694364/22469bd94c2e/12886_2024_3824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4635/11694364/965d3734b8b0/12886_2024_3824_Fig2_HTML.jpg

相似文献

1
Association of obesity with orbital fat expansion in thyroid eye disease.肥胖与甲状腺眼病眶脂肪扩张的关联。
BMC Ophthalmol. 2025 Jan 2;25(1):2. doi: 10.1186/s12886-024-03824-9.
2
Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection.甲状腺眼病的眼眶脂肪减压术:回顾性病例分析及最佳病例选择标准
Ophthalmic Plast Reconstr Surg. 2015 May-Jun;31(3):215-8. doi: 10.1097/IOP.0000000000000260.
3
Long-term outcomes of unilateral orbital fat decompression for thyroid eye disease.单侧眼眶脂肪减压术治疗甲状腺眼病的长期疗效。
Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):935-9. doi: 10.1007/s00417-012-2195-1. Epub 2012 Nov 9.
4
Results and predictability of fat-removal orbital decompression for disfiguring graves exophthalmos in an Asian patient population.亚洲患者群体中脂肪去除眼眶减压术治疗Graves病所致容貌毁损性眼球突出的结果及可预测性
Am J Ophthalmol. 2008 Apr;145(4):755-9. doi: 10.1016/j.ajo.2007.11.020. Epub 2008 Feb 1.
5
Graded decompression of orbital fat and wall in patients with Graves' orbitopathy.格雷夫斯眼眶病患者眼眶脂肪和眶壁的分级减压术
Korean J Ophthalmol. 2014 Feb;28(1):1-11. doi: 10.3341/kjo.2014.28.1.1. Epub 2014 Jan 21.
6
Computed Tomography-Based Prediction of Exophthalmos Reduction After Deep Lateral Orbital Wall Decompression for Graves' Orbitopathy.基于计算机断层扫描的 Graves 眼病行深部外侧眶壁减压术后眼球突出度改善的预测。
Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2759-2767. doi: 10.1007/s00417-019-04500-1. Epub 2019 Oct 23.
7
Endoscopic orbital fat decompression for the management of proptosis in Grave's orbitopathy using a laryngeal skimmer blade.采用喉刮匙刀片行内镜眶隔脂肪减压术治疗格雷夫斯眼病所致眼球突出
Eye (Lond). 2019 Dec;33(12):1924-1929. doi: 10.1038/s41433-019-0519-7. Epub 2019 Jul 8.
8
Minimally invasive orbital decompression: local anesthesia and hand-carved bone.微创眼眶减压术:局部麻醉与手工雕刻骨片
Arch Ophthalmol. 2005 Dec;123(12):1671-5. doi: 10.1001/archopht.123.12.1671.
9
Fat-removal orbital decompression for disfiguring proptosis associated with Graves' ophthalmopathy: safety, efficacy and predictability of outcomes.脂肪去除性眼眶减压术治疗Graves眼病相关的毁容性眼球突出:安全性、有效性及预后可预测性
Int Ophthalmol. 2015 Jun;35(3):325-9. doi: 10.1007/s10792-014-9948-2. Epub 2014 Apr 29.
10
[Multi-wall orbital decompression for disfiguring proptosis in patients with mild or moderate thyroid eye disease].[多壁眼眶减压术治疗轻中度甲状腺眼病所致眼球突出畸形]
Zhonghua Yan Ke Za Zhi. 2017 Feb 11;53(2):128-135. doi: 10.3760/cma.j.issn.0412-4081.2017.02.011.

本文引用的文献

1
The Relationship between Obesity-Related Factors and Graves' Orbitopathy: A Pilot Study.肥胖相关因素与格雷夫斯眼病的关系:一项初步研究。
Medicina (Kaunas). 2022 Nov 29;58(12):1748. doi: 10.3390/medicina58121748.
2
Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.控制和甲状腺相关眼病(TAO)眼眶脂肪及发生脂肪生成的 TAO 眼眶成纤维细胞的转录组特征分析。
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):24. doi: 10.1167/iovs.62.9.24.
3
Asymmetric Graves' Orbitopathy.
非对称格雷夫斯眼病。
Front Endocrinol (Lausanne). 2020 Dec 17;11:611845. doi: 10.3389/fendo.2020.611845. eCollection 2020.
4
Immunological Aspects of Graves' Ophthalmopathy.格雷夫斯眼病的免疫学方面。
Biomed Res Int. 2019 Nov 12;2019:7453260. doi: 10.1155/2019/7453260. eCollection 2019.
5
Orbital fat expansion in thyroid eye disease is related to age.甲状腺眼病中的眶脂肪扩张与年龄有关。
Eur J Ophthalmol. 2020 Sep;30(5):1004-1007. doi: 10.1177/1120672119852322. Epub 2019 May 30.
6
Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient.脂肪去除性眼眶减压术治疗甲状腺相关眼病:为合适的患者选择合适的手术。
Saudi J Ophthalmol. 2017 Jul-Sep;31(3):156-161. doi: 10.1016/j.sjopt.2017.05.017. Epub 2017 Jun 14.
7
Long-term outcomes of orbital fat decompression in Graves' orbitopathy.格雷夫斯眼眶病眼眶脂肪减压的长期疗效
Br J Ophthalmol. 2018 Jan;102(1):69-73. doi: 10.1136/bjophthalmol-2016-309888. Epub 2017 Apr 27.
8
Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.甲状腺眼病的发病机制:分子机制的综述与更新
Br J Ophthalmol. 2016 Jan;100(1):142-50. doi: 10.1136/bjophthalmol-2015-307399. Epub 2015 Nov 13.
9
Normal values of Hertel exophthalmometry in a Chinese Han population from Shenyang, Northeast China.中国东北沈阳汉族人群Hertel眼球突出计测量的正常值。
Sci Rep. 2015 Feb 23;5:8526. doi: 10.1038/srep08526.
10
Hypothyroidism after hemithyroidectomy.甲状腺半切术后甲状腺功能减退症
World J Surg. 2013 Dec;37(12):2839-44. doi: 10.1007/s00268-013-2201-8.